Millions of people live with atrial fibrillation, a racing, uneven heartbeat that can leave you exhausted and scared. Yet it ...

Currently available therapies such as niacin and PCSK9 inhibitors such as Repatha (evolocumab) and Praluent (alirocumab) can reduce Lp (a) levels, but their impact is modest. Another challenge in ...

With 38% of U.S. adults living with high cholesterol, experts say understanding how statins work — and whether you need them ...

Researchers found cardiovascular drugs were associated with 24.7 percent of all medication errors, followed by antibiotics at 19.1 percent, electrolytes at 11.3 percent, endocrine drugs at 8.8 percent ...

The SGLT2 inhibitor empagliflozin (Jardiance) showed some potential for heart failure (HF) prevention in high-risk, ...

Questions/Answers on Thrombotic Issues in SARS-CoV-2 Infection This paper provides practical advice on risk stratification, antithrombotic prophylaxis, and ...

Everyone's talking about weight loss drugs like Ozempic, Wegovy and Mounjaro and their implications on weight loss - but ...

Helps individuals living with heart failure, or those at risk of developing it, by reducing complications and lowering the risk of serious cardiovascular problems ...

Physicians used significantly lower amounts of two heart drugs in hospital settings following major price spikes on the medications, according to Cleveland Clinic research published Thursday in The ...

Metabolic dysfunction-associated steatotic liver disease is the most common liver disease in the world, affecting about one-third of the adult population. This disorder is characterized by the ...

The FDA states new diabetes drugs now need to show a lack of cardiovascular toxicity. Despite initial reservations, companies are cooperating, and some are even seeking the holy grail of ...